Checkpoint Therapeutics Stock (NASDAQ: CKPT) stock price, news, charts, stock research, profile.
You can purchase shares of Checkpoint Therapeutics (NASDAQ:CKPT) through any online brokerage.
Other companies in Checkpoint Therapeutics’s space includes: Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Atossa Therapeutics (NASDAQ:ATOS), PepGen (NASDAQ:PEPG) and Adaptimmune Therapeutics (NASDAQ:ADAP).
Checkpoint Therapeutics has a consensus price target of $28.00.
The stock price for Checkpoint Therapeutics (NASDAQ: CKPT) is $3.34 last updated November 20, 2024 at 5:35 PM EST.
There are no upcoming dividends for Checkpoint Therapeutics.
Checkpoint Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Checkpoint Therapeutics.
Checkpoint Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.